Research and Markets: Global Ischemic Stroke Therapeutics Pipeline Review, H2 2015

Research and Markets (http://www.researchandmarkets.com/research/4hb5rg/ischemic_stroke) has announced the addition of the "Ischemic Stroke - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ischemic Stroke and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • AB Science SA
  • Acticor Biotech
  • advanceCor GmbH
  • Angion Biomedica Corp.
  • AstraZeneca Plc
  • Athersys, Inc.
  • biOasis Technologies Inc.
  • Biogen, Inc.
  • BioTime, Inc.
  • D-Pharm Ltd.
  • Daiichi Sankyo Company, Limited
  • DiaMedica Inc.
  • Digna Biotech, S.L.
  • Genervon Biopharmaceuticals, LLC
  • Glialogix, Inc.
  • Glucox Biotech AB
  • Grifols, S.A.
  • Huons Co., Ltd.
  • International Stem Cell Corporation
  • JN-International Medical Corporation
  • Laboratoires Pierre Fabre SA
  • Lumosa Therapeutics Co., Ltd.
  • MediaPharma s.r.l.
  • Mitsubishi Tanabe Pharma Corporation
  • Neuralstem, Inc.
  • Neurotec Pharma SL
  • NeuroVive Pharmaceutical AB
  • NoNO, Inc.
  • Panacea Pharmaceuticals, Inc.
  • Pharmicell Co., Ltd.
  • PhytoHealth Corporation
  • Remedy Pharmaceuticals, Inc.
  • ReNeuron Group Plc
  • SanBio, Inc.
  • Virogenomics, Inc.

For more information visit http://www.researchandmarkets.com/research/4hb5rg/ischemic_stroke

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular, Central Nervous System

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.